653 related articles for article (PubMed ID: 33994859)
21. A prognostic model built on amino acid metabolism patterns in HPV-associated head and neck squamous cell carcinoma.
Jing F; Zhu L; Bai J; Zhou X; Sun L; Zhang H; Li T
Arch Oral Biol; 2024 Jul; 163():105975. PubMed ID: 38626700
[TBL] [Abstract][Full Text] [Related]
22. Cleaved NOTCH1 Expression Pattern in Head and Neck Squamous Cell Carcinoma Is Associated with NOTCH1 Mutation, HPV Status, and High-Risk Features.
Rettig EM; Chung CH; Bishop JA; Howard JD; Sharma R; Li RJ; Douville C; Karchin R; Izumchenko E; Sidransky D; Koch W; Califano J; Agrawal N; Fakhry C
Cancer Prev Res (Phila); 2015 Apr; 8(4):287-95. PubMed ID: 25633867
[TBL] [Abstract][Full Text] [Related]
23. Loss of LRP1B expression drives acquired chemo and radio-resistance in HPV-positive head and neck cancer.
Shaikh MH; Dawson A; Prokopec SD; Barrett JW; Y F Zeng P; Khan MI; Ryan SEB; Cecchini M; Palma DA; Mymryk JS; Boutros PC; Nichols AC
Oral Oncol; 2023 Nov; 146():106580. PubMed ID: 37778229
[TBL] [Abstract][Full Text] [Related]
24. Investigating the Feasibility of Targeted Next-Generation Sequencing to Guide the Treatment of Head and Neck Squamous Cell Carcinoma.
Lim SM; Cho SH; Hwang IG; Choi JW; Chang H; Ahn MJ; Park KU; Kim JW; Ko YH; Ahn HK; Cho BC; Nam BH; Chun SH; Hong JH; Kwon JH; Choi JG; Kang EJ; Yun T; Lee KW; Kim JH; Kim JS; Lee HW; Kim MK; Jung D; Kim JE; Keam B; Yun HJ; Kim S; Kim HR
Cancer Res Treat; 2019 Jan; 51(1):300-312. PubMed ID: 29747488
[TBL] [Abstract][Full Text] [Related]
25. The role of the antileukoprotease SLPI in smoking-induced human papillomavirus-independent head and neck squamous cell carcinomas.
Quabius ES; Möller P; Haag J; Pfannenschmidt S; Hedderich J; Görögh T; Röcken C; Hoffmann M
Int J Cancer; 2014 Mar; 134(6):1323-34. PubMed ID: 23996702
[TBL] [Abstract][Full Text] [Related]
26. Combinational chromosomal aneuploidies and HPV status for prediction of head and neck squamous cell carcinoma prognosis in biopsies and cytological preparations.
Wemmert S; Linxweiler M; Lerner C; Bochen F; Kulas P; Linxweiler J; Smola S; Urbschat S; Wagenpfeil S; Schick B
J Cancer Res Clin Oncol; 2018 Jun; 144(6):1129-1141. PubMed ID: 29560516
[TBL] [Abstract][Full Text] [Related]
27. Distinct pattern of TP53 mutations in human immunodeficiency virus-related head and neck squamous cell carcinoma.
Gleber-Netto FO; Zhao M; Trivedi S; Wang J; Jasser S; McDowell C; Kadara H; Zhang J; Wang J; William WN; Lee JJ; Nguyen ML; Pai SI; Walline HM; Shin DM; Ferris RL; Carey TE; Myers JN; Pickering CR;
Cancer; 2018 Jan; 124(1):84-94. PubMed ID: 29053175
[TBL] [Abstract][Full Text] [Related]
28. Distinct immune evasion in APOBEC-enriched, HPV-negative HNSCC.
Messerschmidt C; Obermayer B; Klinghammer K; Ochsenreither S; Treue D; Stenzinger A; Glimm H; Fröhling S; Kindler T; Brandts CH; Schulze-Osthoff K; Weichert W; Tinhofer I; Klauschen F; Keilholz U; Beule D; Rieke DT
Int J Cancer; 2020 Oct; 147(8):2293-2302. PubMed ID: 32468570
[TBL] [Abstract][Full Text] [Related]
29. Bioinformatic analysis identifies HPV-related tumor microenvironment remodeling prognostic biomarkers in head and neck squamous cell carcinoma.
Zhou Q; Yuan O; Cui H; Hu T; Xiao GG; Wei J; Zhang H; Wu C
Front Cell Infect Microbiol; 2022; 12():1007950. PubMed ID: 36425786
[TBL] [Abstract][Full Text] [Related]
30. The role of miRNAs in human papilloma virus (HPV)-associated cancers: bridging between HPV-related head and neck cancer and cervical cancer.
Lajer CB; Garnæs E; Friis-Hansen L; Norrild B; Therkildsen MH; Glud M; Rossing M; Lajer H; Svane D; Skotte L; Specht L; Buchwald C; Nielsen FC
Br J Cancer; 2012 Apr; 106(9):1526-34. PubMed ID: 22472886
[TBL] [Abstract][Full Text] [Related]
31. The frequency of high-risk human papillomavirus types, HPV16 lineages, and their relationship with p16
Pakdel F; Farhadi A; Pakdel T; Andishe-Tadbir A; Alavi P; Behzad-Behbahani A; Ashraf MJ
Braz J Microbiol; 2021 Mar; 52(1):195-206. PubMed ID: 33169334
[TBL] [Abstract][Full Text] [Related]
32. Dynamic changes of the EMT spectrum between circulating tumor cells and the tumor microenvironment in human papillomavirus-positive head and neck squamous cell carcinoma.
Ida S; Takahashi H; Tada H; Mito I; Matsuyama T; Chikamatsu K
Oral Oncol; 2023 Feb; 137():106296. PubMed ID: 36571985
[TBL] [Abstract][Full Text] [Related]
33. Characterization of Epigenomic Alterations in HPV16+ Head and Neck Squamous Cell Carcinomas.
Berglund A; Muenyi C; Siegel EM; Ajidahun A; Eschrich SA; Wong D; Hendrick LE; Putney RM; Kim S; Hayes DN; Shibata D
Cancer Epidemiol Biomarkers Prev; 2022 Apr; 31(4):858-869. PubMed ID: 35064062
[TBL] [Abstract][Full Text] [Related]
34. Cannabinoids Promote Progression of HPV-Positive Head and Neck Squamous Cell Carcinoma via p38 MAPK Activation.
Liu C; Sadat SH; Ebisumoto K; Sakai A; Panuganti BA; Ren S; Goto Y; Haft S; Fukusumi T; Ando M; Saito Y; Guo T; Tamayo P; Yeerna H; Kim W; Hubbard J; Sharabi AB; Gutkind JS; Califano JA
Clin Cancer Res; 2020 Jun; 26(11):2693-2703. PubMed ID: 31932491
[TBL] [Abstract][Full Text] [Related]
35. Molecular subclassification determined by human papillomavirus and epidermal growth factor receptor status is associated with the prognosis of oropharyngeal squamous cell carcinoma.
Nakano T; Yamamoto H; Nakashima T; Nishijima T; Satoh M; Hatanaka Y; Shiratsuchi H; Yasumatsu R; Toh S; Komune S; Oda Y
Hum Pathol; 2016 Apr; 50():51-61. PubMed ID: 26997438
[TBL] [Abstract][Full Text] [Related]
36. Discovery and development of differentially methylated regions in human papillomavirus-related oropharyngeal squamous cell carcinoma.
Ren S; Gaykalova D; Wang J; Guo T; Danilova L; Favorov A; Fertig E; Bishop J; Khan Z; Flam E; Wysocki PT; DeJong P; Ando M; Liu C; Sakai A; Fukusumi T; Haft S; Sadat S; Califano JA
Int J Cancer; 2018 Nov; 143(10):2425-2436. PubMed ID: 30070359
[TBL] [Abstract][Full Text] [Related]
37. Frequent HPV-independent p16/INK4A overexpression in head and neck cancer.
Lechner M; Chakravarthy AR; Walter V; Masterson L; Feber A; Jay A; Weinberger PM; McIndoe RA; Forde CT; Chester K; Kalavrezos N; O'Flynn P; Forster M; Jones TM; Vaz FM; Hayes DN; Fenton TR
Oral Oncol; 2018 Aug; 83():32-37. PubMed ID: 30098776
[TBL] [Abstract][Full Text] [Related]
38. Comprehensive genomic profiling of head and neck squamous cell carcinoma reveals FGFR1 amplifications and tumour genomic alterations burden as prognostic biomarkers of survival.
Dubot C; Bernard V; Sablin MP; Vacher S; Chemlali W; Schnitzler A; Pierron G; Ait Rais K; Bessoltane N; Jeannot E; Klijanienko J; Mariani O; Jouffroy T; Calugaru V; Hoffmann C; Lesnik M; Badois N; Berger F; Le Tourneau C; Kamal M; Bieche I
Eur J Cancer; 2018 Mar; 91():47-55. PubMed ID: 29331751
[TBL] [Abstract][Full Text] [Related]
39. The Proteomic Landscape of Growth Factor Signaling Networks Associated with
Chen Z; Zhang C; Chen J; Wang D; Tu J; Van Waes C; Saba NF; Chen ZG; Chen Z
Cancer Res; 2021 Sep; 81(17):4402-4416. PubMed ID: 34167951
[TBL] [Abstract][Full Text] [Related]
40. DNA methylation regulated microRNAs in HPV-16-induced head and neck squamous cell carcinoma (HNSCC).
Sannigrahi MK; Sharma R; Singh V; Panda NK; Rattan V; Khullar M
Mol Cell Biochem; 2018 Nov; 448(1-2):321-333. PubMed ID: 29455435
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
